These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37139365)

  • 41. COVID-19: gastrointestinal symptoms from the view of gut-lung axis.
    Zhang M; Zhou Y; Li H; Peng Y; Qiu P; Shi X; Pan X; Liu J
    Eur J Gastroenterol Hepatol; 2021 May; 33(5):610-612. PubMed ID: 33136724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
    Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut Microbiome Alterations in COVID-19.
    Zuo T; Wu X; Wen W; Lan P
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):679-688. PubMed ID: 34560321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes.
    Chen J; Vitetta L
    Front Biosci (Schol Ed); 2022 Aug; 14(3):23. PubMed ID: 36137978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bmal1 and Gut-lung axis in SARS-CoV-2 infection: New insight into the effects of melatonin on COVID-19 patients?
    Khezri MR; Varzandeh R; Ghasemnejad-Berenji M
    Biomed Pharmacother; 2023 Aug; 164():114291. PubMed ID: 37257225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of SARS-CoV2 infection on gut microbiota dysbiosis.
    Xiao Z; Pan M; Li X; Zhao C
    Microbiome Res Rep; 2024; 3(1):7. PubMed ID: 38455085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
    Suryana KD; Simadibrata M; Renaldi K
    Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
    Xiang Z; Koo H; Chen Q; Zhou X; Liu Y; Simon-Soro A
    J Oral Microbiol; 2020 Nov; 13(1):1853451. PubMed ID: 33312449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.
    Villapol S
    Transl Res; 2020 Dec; 226():57-69. PubMed ID: 32827705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and meta-analysis.
    Benvari S; Mahmoudi S; Mohammadi M
    World J Pediatr; 2022 Sep; 18(9):582-588. PubMed ID: 35665477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.
    Tieu V; Tibi S; Ling J
    Front Cell Infect Microbiol; 2023; 13():1167827. PubMed ID: 37457959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study.
    Zhang L; Xu Z; Mak JWY; Chow KM; Lui G; Li TCM; Wong CK; Chan PKS; Ching JYL; Fujiwara Y; Chan FKL; Ng SC
    J Gastroenterol Hepatol; 2022 May; 37(5):823-831. PubMed ID: 35170078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.
    Park SK; Lee CW; Park DI; Woo HY; Cheong HS; Shin HC; Ahn K; Kwon MJ; Joo EJ
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1387-1394.e2. PubMed ID: 32534042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy.
    Asai N; Kato H; Mikamo H
    Respir Investig; 2022 Jul; 60(4):496-502. PubMed ID: 35422403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Herbal medicine in the treatment of COVID-19 based on the gut-lung axis.
    He Q; Shi Y; Tang Q; Xing H; Zhang H; Wang M; Chen X
    Acupunct Herb Med; 2022 Sep; 2(3):172-183. PubMed ID: 37808350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Public Database-Driven Insights Into Aging Stress-Associated Defective Gut Barrier With Low SARS-CoV-2 Receptors.
    Moon Y
    Front Med (Lausanne); 2020; 7():606991. PubMed ID: 33415119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of probiotics to combat viral infections with emphasis on COVID-19.
    Sundararaman A; Ray M; Ravindra PV; Halami PM
    Appl Microbiol Biotechnol; 2020 Oct; 104(19):8089-8104. PubMed ID: 32813065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
    Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
    Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.